Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581594 · ClinicalTrials.gov registry record · NA
Traditional vs. Graft-augmented Posterior Colporrhaphy
A NA study, sponsored by University of California, Irvine.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00581594 is a NA study that was terminated before completion, run by University of California, Irvine. The registered enrollment target is 8 participants.
The verdict
NCT00581594, a NA study, was terminated before completion, sponsored by University of California, Irvine.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Women who undergo posterior colporrhaphy with graft augmentation will have a lower recurrence of their posterior wall defect than women who undergo a traditional posterior colporrhaphy.
Interventions
- PROCEDURE Graft-augmented colporrhaphy
- PROCEDURE Traditional posterior colporrhaphy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-10-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00581594
The ClinicalTrials.gov registry entry for NCT00581594 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Graft-augmented colporrhaphy is the first listed.
NCT00581594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00581594 about?
NCT00581594 is a clinical study titled "Traditional vs. Graft-augmented Posterior Colporrhaphy". Women who undergo posterior colporrhaphy with graft augmentation will have a lower recurrence of their posterior wall defect than women who undergo a traditional posterior colporrhaphy.
What is the current status of trial NCT00581594?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2006-01. Estimated completion is 2008-10-11.
What interventions are being tested in trial NCT00581594?
The interventions under investigation include: Graft-augmented colporrhaphy (PROCEDURE), Traditional posterior colporrhaphy (PROCEDURE).
Who is sponsoring clinical trial NCT00581594?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.